Genetically Augmenting Aβ42 Levels in Skeletal Muscle Exacerbates Inclusion Body Myositis-Like Pathology and Motor Deficits in Transgenic Mice
- 30 June 2006
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 168 (6) , 1986-1997
- https://doi.org/10.2353/ajpath.2006.051232
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AG 20335)
This publication has 48 references indexed in Scilit:
- Pathogenic accumulation of APP in fast twitch muscle of IBM patients and a transgenic modelNeurobiology of Aging, 2006
- Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic MiceNeuron, 2005
- Tau aggregates are abnormally phosphorylated in inclusion body myositis and have an immunoelectrophoretic profile distinct from other tauopathiesNeuropathology and Applied Neurobiology, 2004
- Triple-Transgenic Model of Alzheimer's Disease with Plaques and TanglesNeuron, 2003
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In VivoNeuron, 1996
- Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1Nature, 1996
- Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and ThreonineJournal of Biological Chemistry, 1995
- β-amyloid precursor protein mRNA is increased in inclusion-body myositis muscleNeuroReport, 1993